BIRC5 and pancreatic neoplasm: YM155 administration in a model with BIRC5 deletion shrank the metastatic foci in SW1990-bearing mice, thus indicating that BIRC5 in CTCs is a key coordinator of the metastasis of pancreatic cancer (71).